JP2024529022A5 - - Google Patents
Info
- Publication number
- JP2024529022A5 JP2024529022A5 JP2024506897A JP2024506897A JP2024529022A5 JP 2024529022 A5 JP2024529022 A5 JP 2024529022A5 JP 2024506897 A JP2024506897 A JP 2024506897A JP 2024506897 A JP2024506897 A JP 2024506897A JP 2024529022 A5 JP2024529022 A5 JP 2024529022A5
- Authority
- JP
- Japan
- Prior art keywords
- oral formulation
- formulation according
- individual
- pharmaceutically acceptable
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163229387P | 2021-08-04 | 2021-08-04 | |
| US63/229,387 | 2021-08-04 | ||
| PCT/US2022/074469 WO2023015206A1 (en) | 2021-08-04 | 2022-08-03 | Method of treating posttraumatic stress disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529022A JP2024529022A (ja) | 2024-08-01 |
| JP2024529022A5 true JP2024529022A5 (https=) | 2025-03-06 |
Family
ID=83149040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506897A Pending JP2024529022A (ja) | 2021-08-04 | 2022-08-03 | 心的外傷後ストレス障害を治療する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240335441A1 (https=) |
| EP (1) | EP4380571A1 (https=) |
| JP (1) | JP2024529022A (https=) |
| KR (1) | KR20240046737A (https=) |
| CN (1) | CN118284419A (https=) |
| AU (1) | AU2022323513A1 (https=) |
| CA (1) | CA3227681A1 (https=) |
| MX (1) | MX2024001673A (https=) |
| TW (1) | TW202320779A (https=) |
| WO (1) | WO2023015206A1 (https=) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602007011793D1 (de) * | 2006-10-18 | 2011-02-17 | Pfizer Prod Inc | Biaryl-ether-harnstoffverbindungen |
-
2022
- 2022-08-03 CA CA3227681A patent/CA3227681A1/en active Pending
- 2022-08-03 JP JP2024506897A patent/JP2024529022A/ja active Pending
- 2022-08-03 AU AU2022323513A patent/AU2022323513A1/en active Pending
- 2022-08-03 EP EP22761888.1A patent/EP4380571A1/en active Pending
- 2022-08-03 CN CN202280058527.2A patent/CN118284419A/zh active Pending
- 2022-08-03 US US18/294,129 patent/US20240335441A1/en active Pending
- 2022-08-03 KR KR1020247007299A patent/KR20240046737A/ko active Pending
- 2022-08-03 WO PCT/US2022/074469 patent/WO2023015206A1/en not_active Ceased
- 2022-08-03 MX MX2024001673A patent/MX2024001673A/es unknown
- 2022-08-03 TW TW111129103A patent/TW202320779A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100528151C (zh) | 莫达非尼药物剂型 | |
| CN1146412C (zh) | 去甲肾上腺素再摄取抑制剂在制备用于治疗对抗挑衅症的药物中的用途 | |
| JP2007533686A5 (https=) | ||
| JP2021527092A5 (https=) | ||
| CN1271278A (zh) | 行为障碍的治疗方法 | |
| JP2022153638A5 (https=) | ||
| JP2022516662A5 (https=) | ||
| JP2016506933A5 (https=) | ||
| JP2021152060A (ja) | アカンプロセートおよびｄ−サイクロセリンを使用する組み合わせ療法 | |
| JP2022554276A5 (https=) | ||
| CN1141937C (zh) | 含有曲马朵的药物组合物用于制备治疗偏头痛或类偏头痛的药物 | |
| JP2024507810A5 (https=) | ||
| CN113710319B (zh) | 用于治疗焦虑相关病症的组合物和方法 | |
| JPWO2023054732A5 (https=) | ||
| JP2007506801A (ja) | モダフィニルおよび他の薬剤を含んでなる製薬学的組成物 | |
| JP2023549849A5 (https=) | ||
| JPS6110509A (ja) | 医薬組成物 | |
| JP2017508737A5 (https=) | ||
| JP2023502053A5 (https=) | ||
| JP2024529022A5 (https=) | ||
| JP5341037B2 (ja) | 双極性障害を処置するための医薬を得るためのアゴメラチンの使用 | |
| JP2021530568A5 (https=) | ||
| CN115607545B (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| JP7527662B2 (ja) | ピモジドとメトトレキサートの医薬組成物、及びその使用 | |
| JP2025503646A5 (https=) |